EUVIMEDScopri EUVIMED
CrossrefScheda informativa

The Scm FCS finger binds the Pcl Tudor domain to link canonical PRC1 and PRC2 .1 in Drosophila

Berfin Yesil, Barbara Steigenberger, Jacques Bonnet, Jürg Müller

Protein Science · 2026-12 · 35 (12)

DOI: 10.1002/pro.70855 ↗
AbstractDati bibliografici

Abstract

Abstract Canonical Polycomb Repressive Complex 1 (PRC1) was previously reported to selectively associate with Polycomb Repressive Complex 2.1 (PRC2.1) in cross‐linking‐based affinity purification experiments from Drosophila embryos, but the molecular basis of this interaction has remained unresolved. Here, we established an affinity‐purification strategy using cryo‐milled Drosophila embryos that recovers intact canonical PRC1 together with the complete PRC2.1 complex without chemical cross‐linking. Using AlphaFold3 to systematically model interactions between canonical PRC1 and PRC2.1 subunits, we identified a single high‐confidence interface between the FCS finger of the canonical PRC1 accessory subunit Sex comb on midleg (Scm) and the atypical Tudor domain of the PRC2.1 accessory subunit Polycomblike (Pcl). Recombinant Scm FCS finger and Pcl Tudor domain formed a stable complex in vitro, as demonstrated by size‐exclusion chromatography and native mass spectrometry. Structure‐guided mutagenesis validated the predicted interface: point mutations in either interaction partner abolished complex formation, whereas complementary charge‐reversal mutations restored binding. These findings identify the Scm–Pcl interaction as the molecular basis for the selective association between canonical PRC1 and PRC2.1 in Drosophila and reveal that communication between these complexes is mediated by a direct interaction between these accessory subunits.

Conoscenze adatte al tuo lavoro.

Dall’inizio gratuito alla ricerca bibliografica personale, fino alla Research Suite completa.

Visualizza tariffe →

Sono inclusi tutti i testi integrali degli editori?

No. Citazioni, abstract e testi integrali sono contenuti diversi. La disponibilità dipende dalla fonte, dall’accesso aperto e dalle licenze esistenti. Un piano EUVIMED non sostituisce diritti aggiuntivi degli editori.

Visualizza tariffe →